NEIL TROSSEVIN: Open Payments
NPI 1265496186 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,706 in 70 payments from 22 companies in 2025. Trend: 2023 $1,098 · 2024 $1,341 · 2025 $1,706
Food & beverage: $1,706
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 14 | $324 |
| Astellas Pharma US Inc | 5 | $145 |
| PFIZER INC. | 5 | $121 |
| Medtronic, Inc. | 4 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $115 |
| Tempus AI, Inc | 4 | $102 |
| Janssen Biotech, Inc. | 4 | $93 |
| Ferring Pharmaceuticals Inc. | 3 | $82 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $69 |
| Procept Biorobotics Corporation | 2 | $68 |
Products named: Xtandi, ORGOVYX, GEMTESA, INTERSTIM, Nubeqa, XT CDX, ERLEADA, ADSTILADRIN.
Industry payments across GA — which companies pay providers there.
